Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
JAMA Oncology|November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialAndrea Cercek, Thomas Boerner, Benjamin R Tan, et al.
Nature Genetics|April 5, 2020
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancerAlex H Wagner, Brian Walsh, Georgia Mayfield, et al.
Nature Cell Biology|June 30, 2017
Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasisVeronica Torrano, Lorea Valcarcel-Jimenez, Ana Rosa Cortazar, et al.
Cancer Discovery|March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging TherapiesEmmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Nature Genetics|November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesisPreethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
Acta Neuropathologica|September 12, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumorsSubhiksha Nandakumar, Miika Mehine, Yelena Kemel, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
JAMA Oncology|November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialAndrea Cercek, Thomas Boerner, Benjamin R Tan, et al.
Nature Genetics|April 5, 2020
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancerAlex H Wagner, Brian Walsh, Georgia Mayfield, et al.
Nature Cell Biology|June 30, 2017
Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasisVeronica Torrano, Lorea Valcarcel-Jimenez, Ana Rosa Cortazar, et al.
Cancer Discovery|March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging TherapiesEmmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Nature Genetics|November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesisPreethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
Acta Neuropathologica|September 12, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumorsSubhiksha Nandakumar, Miika Mehine, Yelena Kemel, et al.
Pageof 31